Remove Diabetes Remove Documentation Remove Labelling
article thumbnail

STAT+: Pharmalittle: We’re reading about Wegovy approved for heart risks, an ALS drug puzzle, and more

STAT

Food and Drug Administration approved a label expansion for Novo Nordisk’s obesity drug Wegovy to tout its benefits for the heart, a move that could boost demand and insurance coverage for the already highly popular treatment , STAT notes. The  And of course, do keep in touch. … The U.S.

Labelling 283
article thumbnail

Off-label Use

RX Note

In fact, off-label drug uses can become widely entrenched in clinical practice and become predominant treatments for a given clinical condition. In a study published in JAMA Internal Medicine , off-label use lacking strong scientific evidence had a higher adverse drug event rate compared with on-label use.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Spurious drugs worth Rs. 6.60 cr seized in Kolkata

Express Pharma

The raid, carried out at M/s Care and Cure For You in Kolkata, resulted in the seizure of a large quantity of anti-cancer, anti-diabetic, and other drugs suspected to be spurious. In the absence of such documentation, these drugs are deemed to be spurious.

article thumbnail

Herbs and Supplements

RX Note

I heard fenugreek is helpful for diabetes management. FDA requires the labels of all herbal supplements to include the complete list of ingredients and manufacturers must follow good manufacturing practices (GMP) to ensure that supplements are processed consistently and meet quality standards. Is that true? Monitor therapy.

article thumbnail

Chronic Disease Solutions: Spotlight on COVID-19 and its Impact on Heart Disease

PharmD Live

Acute cardiac injury has been a well-documented feature of infection with SARS-CoV-2, which causes COVID-19 among patients requiring hospitalization. Aspirin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial,The Lancet, Volume 399, Issue 10320, 2022, Pages 143-151,ISSN 0140-6736.

article thumbnail

NHC Comments on Medicare Drug Price Negotiation Program: Draft Guidance, Implementation of Sections 1191 – 1198 of the Social Security Act for Initial Price Applicability Year 2027 and Manufacturer Effectuation of the Maximum Fair Price (MFP) in 2026 and 2027

Putting Patients First Blog

The NHC requests more clarity on how CMS will exclude QALY-based metrics and highlight when they have been removed from consideration in MFP justification documentation. Similarly, long-acting insulin analogs provide more stable blood sugar control and reduce the number of daily injections needed for diabetes patients. hstc=117268889.c6acac5669d4f1e6063a774e6d96c6b5.1716560813145.1716560813145.1716560813145.1&

article thumbnail

Learning Module

RX Note

What are the legal requirements of labelling on a medication for a dispensed medicine by pharmacist? Explain on disposal/write-off of stocks and its procedures and documentation. Can metformin be continued in diabetes during pregnancy ? Are pharmacists allowed to sell poisons to a person under 18 years old ?